nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addressing the Human Experience of Chronic Kidney Disease: A Call to Transform Kidney Care
|
Correa-Rotter, Ricardo |
|
|
42 |
2 |
p. 559-567 |
artikel |
2 |
Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data
|
Young, Corinne |
|
|
42 |
2 |
p. 830-848 |
artikel |
3 |
An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases
|
Yang, Min |
|
|
42 |
2 |
p. 568-578 |
artikel |
4 |
An Indirect Treatment Comparison of Lenvatinib for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma
|
Ndirangu, Kerigo |
|
|
42 |
2 |
p. 977-994 |
artikel |
5 |
A Pharmacoeconomic Study of Post-Exposure Prophylaxis Strategies for Influenza Virus Infections in Japan
|
Nakagawa, Naoto |
|
|
42 |
2 |
p. 772-787 |
artikel |
6 |
Assessment of the Potential Clinical and Economic Impact of Weight Loss in the Adult Population with Obesity and Associated Comorbidities in Spain
|
Ballesteros-Pomar, María Dolores |
|
|
42 |
2 |
p. 1265-1282 |
artikel |
7 |
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
|
Lugogo, Njira L. |
|
|
42 |
2 |
p. 849-862 |
artikel |
8 |
CKD-Associated Pruritus is Associated with Greater Use of Antidepressants and Anti-pruritus Medications
|
Ion Titapiccolo, Jasmine |
|
|
42 |
2 |
p. 1283-1289 |
artikel |
9 |
Clinical Features and Current Pharmacotherapy of OAB in Practice: Ideal and Reality
|
Tsubouchi, Kazuna |
|
|
42 |
2 |
p. 1094-1107 |
artikel |
10 |
Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease
|
Mannino, David |
|
|
42 |
2 |
p. 1131-1146 |
artikel |
11 |
Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors
|
Mease, Philip J. |
|
|
42 |
2 |
p. 734-751 |
artikel |
12 |
Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung Disease
|
McCarrier, Kelly P. |
|
|
42 |
2 |
p. 935-976 |
artikel |
13 |
Correction to: Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years
|
Torres Pradilla, Mauricio |
|
|
42 |
2 |
p. 1290 |
artikel |
14 |
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis
|
Earla, Jagadeswara R. |
|
|
42 |
2 |
p. 886-903 |
artikel |
15 |
Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective
|
Igarashi, Ataru |
|
|
42 |
2 |
p. 995-1008 |
artikel |
16 |
Costs of Oral Corticosteroid Use in Patients with Severe Asthma With/Without Chronic Rhinosinusitis with Nasal Polyps: Data from the Italian SANI Registry
|
Heffler, Enrico |
|
|
42 |
2 |
p. 1196-1206 |
artikel |
17 |
Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice
|
Mignani, Renzo |
|
|
42 |
2 |
p. 597-635 |
artikel |
18 |
Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial
|
Singh, Awadhesh Kumar |
|
|
42 |
2 |
p. 801-812 |
artikel |
19 |
Genetic Etiologies and Outcomes in Malignancy and Mortality in Activated Phosphoinositide 3-Kinase Delta Syndrome: A Systematic Review
|
Büsch, Katharina |
|
|
42 |
2 |
p. 752-771 |
artikel |
20 |
Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis
|
Rudofsky, Gottfried |
|
|
42 |
2 |
p. 788-800 |
artikel |
21 |
Healthcare Utilization, Costs, and Treatment Discontinuation in Adults with Episodic Migraine Initiating Galcanezumab Versus Rimegepant: A US Retrospective Claims Analysis
|
Kim, Gilwan |
|
|
42 |
2 |
p. 918-934 |
artikel |
22 |
Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature Review
|
Azimpour, Khashayar |
|
|
42 |
2 |
p. 579-596 |
artikel |
23 |
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals
|
Spinner, Christoph D. |
|
|
42 |
2 |
p. 666-719 |
artikel |
24 |
Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study
|
Hu, Ying |
|
|
42 |
2 |
p. 904-917 |
artikel |
25 |
Machine Learning Applications in Acute Coronary Syndrome: Diagnosis, Outcomes and Management
|
Nie, Shanshan |
|
|
42 |
2 |
p. 636-665 |
artikel |
26 |
Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)
|
Baptist, Alan P. |
|
|
42 |
2 |
p. 1061-1074 |
artikel |
27 |
One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis
|
Calzavara-Pinton, Piergiacomo |
|
|
42 |
2 |
p. 720-733 |
artikel |
28 |
Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers
|
Wang, Xiaodong |
|
|
42 |
2 |
p. 813-829 |
artikel |
29 |
Population Pharmacokinetic Modeling to Support Trofinetide Dosing for the Treatment of Rett Syndrome
|
Darwish, Mona |
|
|
42 |
2 |
p. 1026-1043 |
artikel |
30 |
Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2–4 Years with Rett Syndrome
|
Darwish, Mona |
|
|
42 |
2 |
p. 1009-1025 |
artikel |
31 |
Qualitative Assessment of Health-Related Quality of Life Impacts Associated with Sickle Cell Disease in the United States and United Kingdom
|
Drahos, Jennifer |
|
|
42 |
2 |
p. 863-885 |
artikel |
32 |
Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19
|
Dreher, Michael |
|
|
42 |
2 |
p. 1237-1250 |
artikel |
33 |
Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia
|
Li, Pengxiang |
|
|
42 |
2 |
p. 1251-1264 |
artikel |
34 |
Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan
|
Inoue, Yoshikazu |
|
|
42 |
2 |
p. 1075-1093 |
artikel |
35 |
Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies
|
Kagan, Risa |
|
|
42 |
2 |
p. 1147-1164 |
artikel |
36 |
Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical Practice
|
Daskalopoulou, Stella S. |
|
|
42 |
2 |
p. 1108-1130 |
artikel |
37 |
The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn’s Disease
|
Dubinsky, Marla |
|
|
42 |
2 |
p. 1044-1060 |
artikel |
38 |
Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study
|
Lam, Ka-On |
|
|
42 |
2 |
p. 1222-1236 |
artikel |
39 |
Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH Database
|
Luthra, Rakesh |
|
|
42 |
2 |
p. 1165-1195 |
artikel |
40 |
US Real-World Effectiveness, Tolerability, and Healthcare Resource Utilization After Addition of Fremanezumab for Preventive Treatment in Patients Using Gepants for Acute Treatment of Migraine: Results From a Retrospective Chart Review
|
Eugeni, Patrick |
|
|
42 |
2 |
p. 1207-1221 |
artikel |